PW Medtech Sets 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Review Interim Dividend

Bulletin Express

Aug 18

PW Medtech Group Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and will also consider declaring an interim dividend.

The board currently comprises: • 1 executive director – Chairman & CEO Yue’e Zhang • 2 non-executive directors – Jiang Liwei and Lin Junshan • 3 independent non-executive directors – Wang Xiaogang, Chen Geng and Wang Fengli

The company disclosed no additional financial figures or dividend details in the announcement dated 18 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1102499825"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1102499825\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1102499825?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102499825","market":"hk","top_or_hot":-1,"title":"PW Medtech Sets 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Review Interim Dividend","media":"Bulletin Express","content":"<p>PW Medtech Group Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and will also consider declaring an interim dividend.</p>\n<p>The board currently comprises:\n• 1 executive director – Chairman & CEO Yue’e Zhang  \n• 2 non-executive directors – Jiang Liwei and Lin Junshan  \n• 3 independent non-executive directors – Wang Xiaogang, Chen Geng and Wang Fengli</p>\n<p>The company disclosed no additional financial figures or dividend details in the announcement dated 18 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PW Medtech Sets 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Review Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPW Medtech Sets 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Review Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 16:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PW Medtech Group Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and will also consider declaring an interim dividend.</p>\n<p>The board currently comprises:\n• 1 executive director – Chairman & CEO Yue’e Zhang  \n• 2 non-executive directors – Jiang Liwei and Lin Junshan  \n• 3 independent non-executive directors – Wang Xiaogang, Chen Geng and Wang Fengli</p>\n<p>The company disclosed no additional financial figures or dividend details in the announcement dated 18 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01358","symbol_name":"普华和顺","start_time":0,"source_url":"","article_id":"1102499825","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102499825","pubTimestamp":1787042912,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"PW Medtech Group Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and will...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01358":"普华和顺"},"translate_title":"PW Medtech 定于 2026 年 8 月 28 日召开董事会会议，批准 2026 年上半年业绩并审查中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01358":1},"content_text":"PW Medtech Group Limited has scheduled a board meeting for 28 August 2026. Directors will review and approve the unaudited consolidated interim results for the six months ended 30 June 2026 and will also consider declaring an interim dividend.\nThe board currently comprises:\n• 1 executive director – Chairman & CEO Yue’e Zhang  \n• 2 non-executive directors – Jiang Liwei and Lin Junshan  \n• 3 independent non-executive directors – Wang Xiaogang, Chen Geng and Wang Fengli\nThe company disclosed no additional financial figures or dividend details in the announcement dated 18 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}